Ocugen (OCGN) Current Leases (2014 - 2026)

Ocugen (OCGN) reported Current Leases of $850000.0 for Q1 2026, up 15.49% on a YoY basis from $736000.0 in Q1 2025, and down 0.93% quarter-over-quarter from $858000.0 in Q4 2025.

Ocugen (OCGN) Current Leases (2014 - 2026) Analysis & Trends

Ocugen has reported Current Leases for 12 years, with the latest figure at $850000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases rose 15.49% year-over-year to $850000.0; the trailing twelve-month figure through Mar 2026 stood at $850000.0 (up 15.49% YoY), and the FY2025 full-year result was $858000.0, up 65.32% from the prior year.
  • Current Leases for Q1 2026 stood at $850000.0, down from $858000.0 in the prior quarter.
  • The five-year high for Current Leases was $858000.0 in Q4 2025, with the low at $254000.0 in Q1 2022.
  • Historically, Current Leases has averaged $579941.2 across 5 years, with a median of $526000.0 in 2023.
  • Annual changes were most pronounced in 2022 — Current Leases soared 157.56% — and 2024, when it fell 12.36%.
  • Ocugen's Current Leases stood at $498000.0 in 2022, then climbed by 15.26% to $574000.0 in 2023, then dropped by 9.58% to $519000.0 in 2024, then soared by 65.32% to $858000.0 in 2025, then decreased by 0.93% to $850000.0 in 2026.
  • The last three Current Leases figures came in at $850000.0 (Q1 2026), $858000.0 (Q4 2025), and $855000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 83,991.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 7.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ocugen 411.07 Mn 411.07 Mn - 850,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 850,000.00
Dec 31, 2025 858,000.00
Sep 30, 2025 855,000.00
Jun 30, 2025 853,000.00
Mar 31, 2025 736,000.00
Dec 31, 2024 519,000.00
Sep 30, 2024 477,000.00
Jun 30, 2024 461,000.00
Mar 31, 2024 589,000.00
Dec 31, 2023 574,000.00
Sep 30, 2023 540,000.00
Jun 30, 2023 526,000.00
Mar 31, 2023 512,000.00
Dec 31, 2022 498,000.00
Sep 30, 2022 443,000.00
Jun 30, 2022 314,000.00
Mar 31, 2022 254,000.00
Dec 31, 2021 363,000.00
Sep 30, 2021 172,000.00
Jun 30, 2021 168,000.00